Zealand Pharma AS (CHIX:ZEALc)
kr 295.4 (0%) Market Cap: 22.46 Bil Enterprise Value: 8.41 Bil PE Ratio: 3.70 PB Ratio: 1.61 GF Score: 43/100

Q2 2026 Zealand Pharma A/S Earnings Call Transcript

Aug 13, 2026 / 12:00PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Zealand Pharma interim report H1 2026 conference call. (Operator Instructions)

Please be advised that todayâs conference is being recorded. I would now like to hand the conference over to your speaker today, Eric Rojas, Vice President and Head of Investor Relations. Please go ahead.

Eric Rojas;S;Vice President
Zealand Pharma A;Head of Investor Relations

/- -

Thank you, Heidi, and thank you everyone for joining us today to discuss Zealand Pharmaâs results for the first half of 2026. The related company announcement is available on our website at zealandpharma.com. As outlined on the slide, I would like to remind listeners that during todayâs call, we will be making forward-looking statements that are subject to risks and uncertainties.

Turning to todayâs agenda, joining me on this call is Adam Steensberg, President and Chief Executive Officer, David Kendall, Chief Medical Officer, and Henriette Wennicke, Chief Financial Officer. All speakers will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot